Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety of intramuscular TAK-816 in healthy Japanese infants.


Clinical Trial Description

The purpose of this study is to evaluate the safety of intramuscular TAK-816 in healthy Japanese infants. The secondary purpose of this study is to evaluate the immunogenicity of intramuscular TAK-816 in healthy Japanese infants. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Prevention of Infections Caused by Haemophilus Influenzae Type b

NCT number NCT02074345
Study type Interventional
Source Takeda
Contact
Status Completed
Phase Phase 3
Start date March 2014
Completion date March 2015